Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NATIONAL INTERGROUP 7.8% STAKE IN SYSTEMED MAY BE SPRINGBOARD

Executive Summary

NATIONAL INTERGROUP 7.8% STAKE IN SYSTEMED MAY BE SPRINGBOARD for a possible acquisition of the pharmacy benefit management firm by the FoxMeyer parent corporation. In an Aug. 5 13D filing with the Securities & Exchange Commission, National Intergroup says it believes that SysteMed "is presently undervalued" and that it "may determine to seek control" of SysteMed. FoxMeyer pointed out Aug. 12 that National Intergroup has numerous investments that are not geared towards acquisitions. The 13D language is intended to preserve all options, FoxMeyer said.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS024901

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel